Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Kiadis Pharma, a Netherlands-based company engaged in the development of new cell-based therapeutics in the field of bone marrow transplantation, has appointed Maarten Egeler as its new chief medical officer.
Subscribe to our email newsletter
Dr Egeler is a pediatric bone marrow transplantation physician and an internationally recognized authority in pediatric hemato-oncology. He brings to Kiadis Pharma over more than 20 years of expertise in this field.
Dr Egeler will join Kiadis Pharma part time next to his position as head of the pediatric oncology and bone marrow transplantation division of the University of Leiden. As Kiadis Pharma’s chief medical officer (CMO), he will oversee all medical affairs of the company and he will work closely with the company’s global network of key opinion leaders in the transplantation community on the development of the company’s products.
Manja Bouman, CEO of Kiadis Pharma, said: “Maarten has been acting as a medical advisor for Kiadis Pharma over the last year and we are very pleased that he agreed to become our CMO.
“The depth of his medical expertise in the field of bone marrow transplantations, his leadership worldwide in haplo-identical transplantation and his network with key opinion leaders in the field will greatly contribute to the success of our products and company.”